Category Archives: MS Treatment

Hope for Lee Fundraising for ms treatmentFrom:lchuckryViews:6 1ratingsTime:11:23More inNonprofits Activism See the original post here: Hope for Lee - Video … Continue reading →

Oct. 27, 2012, 4:08 a.m. Shellharbour MP Anna Watson has called on the NSW government to consider a centre for eating disorders in the Illawarra. Ms Watson said she was moved by the experience of 15-year-old Chloe Swinfield, who went public about her three-year battle with anorexia to raise awareness about the loneliness she feels. Chloe, a patient at Westmead Hospital, often feels isolated from her support network and in her darkest hours wants to give up. MORE: Somebody help me, begs Chloe MORE: An open letter to Chloe Swinfield Her desperate mum, Jan Whitton, is struggling financially and with no car the trips to Sydney are taking their toll. Ms Watson urged NSW Minister for Mental Health Kevin Humphries to consider Chloe's plight and improve services in the Illawarra. "I would appreciate your consideration of ... whether it is possible to establish appropriate treatment services for anorexia and other eating disorders in the Illawarra, including the establishment of a centre for eating disorders within the region," Ms Watson said in a letter to the minister this week. Ms Whitton said she was frustrated her daughter was not treated as "someone with a real disease". Read the rest here: MP … Continue reading →

Data reinforces broad therapeutic potential of oral ADX71441 Program on track for CTA filing before end of 2012 Geneva, Switzerland, 29 October 2012 - (ADXN.SW), a leading company pioneering allosteric modulation-based drug discovery and development, announced today positive preclinical data for its GABA-B receptor positive allosteric modulator (PAM) oral small molecule, ADX71441, in a validated rodent model of alcohol binge drinking. ADX71441 demonstrated robust, dose-dependent and long-lasting suppression of alcohol intake in animals compared to naltrexone, the most-commonly prescribed treatment of alcoholism on the market. "These data are extremely encouraging and superior to naltrexone in our pre-clinical model, and warrant further exploration as a novel treatment for alcoholism," said Professor Klaus Miczek at Tufts University (USA) in whose laboratory the study was performed. Both clinical and pre-clinical data suggest that activation of the GABA-B receptor offers a unique therapeutic opportunity to address largely unmet needs of patients with alcohol and drug abuse by (1) reducing the alcohol or drug intake; (2) alleviating many physical signs (pain, Gastrointestinal/urinary disturbances) and emotional symptoms (anxiety) associated with withdrawal; and (3) maintaining abstinence by reducing alcohol or drug craving. ADX71441, which has potential for once daily dosing and selectively activates the GABA-B receptor, was … Continue reading →

NEW YORK (AP) Shares of Biogen Idec Inc. continued to slump Friday after the company said the Food and Drug Administration has delayed a decision on its multiple sclerosis pill BG-12. THE SPARK: On Thursday, Biogen said the FDA had extended its review of BG-12 by three months, which means the agency will make a ruling on the drug at the end of March 2013 instead of by the end of 2012. The Weston, Mass., company said the agency needed additional time to review the data it had submitted and was not asking Biogen to run additional clinical studies of BG-12. Friday was also a down day in the broader markets, as the Standard & Poor's 500 index fell 1.7 percent in afternoon trading. THE BIG PICTURE: Biogen filed for marketing approval of BG-12 early this year, and analysts think the drug will eventually bring the company billions of dollars in annual sales because it could become a leading option in treating multiple sclerosis. In clinical trials, Biogen said patients who took BG-12 were far less likely to have a relapse in symptoms than patients who took a placebo. The drug also worked better than Copaxone, an injection that is … Continue reading →

Ann Romney, wife of presidential candidate Mitt Romney, and Jack Osbourne, son of rocker Ozzy Osbourne, may not have much in common politically. On a personal level, however, they are both battling the same serious illness. With news that both have multiple sclerosis, the national media has revisited this debilitating autoimmune disease that affects about 400,000 people nationwide, 2,500 of them in New Mexico. With MS, a persons immune system attacks the central nervous system, damaging nerve fibers in the brain and spinal cord, explains Albuquerque neurologist Dr. Corey Ford, director of the Multiple Sclerosis Specialty Clinic at the University of New Mexicos Neurosciences Center. It does not affect the nerves in the arms or legs, or the muscles directly. The nerve damage that does result can show up as a variety of symptoms, including vision loss, weakness, sensations of numbness or tingling, loss of balance and mobility issues, bladder and bowel problems, dizziness, tremors, spasticity and problems with cognition including short-term memory loss, slowed thinking and difficulty with multitasking. Which MS patients manifest which symptoms, to what degree and for how long is the big unknown, says Ford. Albuquerquean Dave Bexfield, 44, first noticed intermittent symptoms in 2006 flashes … Continue reading →

The care a Perth man provided to his wife who had multiple sclerosis and was malnourished and had infected bed sores when she died five years ago is being investigated by the coroner with a suggestion the case involved "likley neglect". Coroner Dominic Mulligan is examining the circumstances surrounding Mrs Devine's death, particularly the quality of care provided by her husband Andrew Devine. Mrs Devine was diagnosed with MS in 1999 and both she and her husband were registered nurses. Counsel assisting the coroner Melanie Smith told the inquest this case involved "likely neglect". Ms Smith told the court Mrs Devine was only hospitalised twice in the last two years of her life and questions would also be raised about her treatment by health professionals. She said she wanted to make it plain that the case could be referred to the Office of the Director of Public Prosecutions if the evidence heard at the inquest indicated an indictable offence or offences had been committed in connection with Mrs Devine's death. "The cause of death is in issue in this matter, in particular whether Mrs Devine's MS or the consequences of her likely neglect were the cause," Ms Smith said. Forensic … Continue reading →

Ben Gommers, with his mother, Arts Minister Ros Bates. Photo: Supplied Arts Minister Ros Bates's son Ben Gommers has been hospitalised for depression after "incorrect and sensational" media reports put him under enormous stress, according to his mother. Ms Bates released a statement this afternoon saying she informed the Premier she will be taking additional medical leave to recover from shoulder surgery as well as spend time with her 25-year-old son who is under the care of a specialist while he seeks treatment for depression. The statement comes after a week in which the Transport Director-General Michael Caltabiano stepped down to face a parliamentary probe over allegations he misled estimates hearings over his professional connection to Mr Gommers' lobbying firm Entree Vous. "My attempts to return to work were premature and Ive accepted medical advice that further rest is required," Ms Bates said. Advertisement "During this period, Ill be spending time with my son Ben who has been under enormous stress and continued scrutiny from often incorrect and sensational reporting of his chosen career. "On Monday, October 22, Ben was admitted to hospital to be treated for depression "I will always be a mother first and an MP and Minister … Continue reading →

Phil (centre) with HAD's driving centre manager David Wooder (left) and driving assessor Sean Lawrence By Laura Burge Sunday, October 28, 2012 7:02 AM A FORMER soldier who was diagnosed with both prostate cancer and MS at the same time has spoken out about how he has overcome obstacles to keep up his independence. To send a link to this page to a friend, simply enter their email address below. The message will include the name and email address you gave us when you signed up. Send link To send a link to this page to a friend, you must be logged in. Phil Davies, from Breachwood Green, was diagnosed in August 2010. The cancer is in remission, and he is receiving specialist treatment for MS. Mr Davies, who served in the Intelligence Corps in Hong Kong, Northern Ireland and Germany, believes he had MS for a while before being diagnosed. But one of the signs which pointed to something being wrong was when he was driving. Excerpt from: Former soldier speaks about fight against cancer and MS … Continue reading →

Lindsay B. Eastman, DDS, MS, PA, joined efforts to treat the millions of American adults who require gum disease treatment. As a Bradenton periodontist, Dr. Eastman wants Floridians who suffer from this disease to seek the treatment that they need before further complications arise. Gum disease not only causes dental issues but has also been linked to other serious illnesses or conditions. The new Laser Assisted New Attachment Procedure is now available at his offices. Bradenton, FL (PRWEB) October 28, 2012 Understanding the actual LANAP procedure may help patients realize that it is minimally invasive and causes little, if any, pain. The procedure begins with Dr. Eastman checking the pocket depths between the gums and the teeth. This is where the bacteria causing the disease reside. The PerioLase MVP-7 laser utilizes pulsating light to destroy the bacteria and to eliminate diseased gum tissue. The doctor then removes tarter or calcium deposits on the teeth. The laser is then used to help the healthy tissue re-attach to the tooth root. Only one percent of dental professionals in the country are trained on this procedure. As a Bradenton periodontist, Dr. Eastman treats patients from all over the state who wish to have … Continue reading →

WESTON, Mass. (AP) Biotech drugmaker Biogen Idec Inc. said Thursday its profit grew more than 13 percent in the third quarter, led by sales of the company's multiple sclerosis treatment Avonex. Company shares rose in afternoon trading as Biogen boosted its annual guidance. The Massachusetts-based company said revenue from Avonex grew 8 percent to $736.2 million in the period. Sales of the company's cancer drug Rituxan grew 8 percent to $288 million. Those gains helped offset sales of the company's older multiple sclerosis treatment, Tysabri, which declined by 1 percent to $275 million. Overall, Biogen earned $398.4 million, or $1.67 per share, up from $351.8 million, or $1.43 in the prior-year period. Total revenue grew 6 percent to $1.39 billion. That performance topped Wall Street expectations. Analysts polled by FactSet expected earnings of $1.59 per share on revenue of $1.38 billion. The company raised its full-year adjusted earnings guidance to between $6.40 and $6.50. That's up from a July forecast when the company predicted earnings above $6.20 per share. Analysts expect $6.44 per share. Shares of Biogen Idec rose $3.58, or 2.5 percent, to $145.64 in afternoon trading. Biogen focuses on treatments for neurodegenerative diseases, hemophilia and autoimmune disorders. Multiple … Continue reading →